Agents and Actions

, Volume 27, Issue 1–2, pp 8–16

Mast cells, neuropeptides and inflammation

  • M. K. Church
  • M. A. Lowman
  • P. H. Rees
  • R. C. Benyon
Plenary Lecture

Conclusions

We have demonstrated that, unlike mast cells of the lung, adenoids, tonsils and intestine, whose primary role is thought to be IgE-mediated host defence, human skin mast cells respond to neuropeptide stimulation with a rapid release of histamine and minimal generation of PGD2 and LTC4. This ability of skin mast cells to release mediators in response to neuropeptide stimulation is evidence in favour of a neuro-immune interaction within human skin which may have evolved to promote angiogenesis [70] or control cutaneous blood flow [71]. In this context, it is interesting to note that mast cells are found in particularly high numbers in the blush areas of the neck and face [72].

A knowledge of the functional heterogeneity of human mast cells, and of their responsiveness to neuropeptides in particular, will prove to be of great importance to our understanding of the role of mast cells in health and disease. Enhanced responsiveness of skin mast cells to neuropeptides may contribute to the aetiology of some forms of urticaria as suggested by the presence of enhanced weal responses of patients with chronic idiopathic urticaria to various non-immunological stimuli [73–76]. Furthermore, the high ratios of histamine to PGD2 (>1000∶1) [31, 32] in the venous effluent of thermally-challenged limbs of patients with heat- or cold-induced urticaria suggests mast cell activation by a neuropeptide rather than an immunological stimulus. However, the caveat applies that these two mediators may have been metabolised to different extents before reaching the sampling site.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    M. W. Greaves, R. Marks and I. Robertson,Receptors for histamine in human skin blood vessels. A review. Br. J. Dermatol.92, 225–228 (1977).Google Scholar
  2. [2]
    T. Lewis,The blood vessels of the human skin and their responses. Shaw, London 1927.Google Scholar
  3. [3]
    J. F. Riley and G. B. West,The presence of histamine in tissue mast cells. J. Physiol (Lond)120, 528–537 (1953).Google Scholar
  4. [4]
    R. A. J. Eady, T. Cowen, T. F. Marshall, V. Plummer and M. W. Greaves,Mast cell population density, blood vessel density and histamine content of normal human skin. Br. J. Dermatol.100, 623–633 (1979).PubMedGoogle Scholar
  5. [5]
    B. Uvnäs, C.-H. Aborg and A. Bergendorff,Storage of histamine in mast cells. Evidence for ionic binding of histamine to protein carboxyls in the granule heparin protein complex. Acta Physiol. Scand.336 (Suppl), 1–26 (1970).Google Scholar
  6. [6]
    F. Golz,Über Gefäßerweiternde Nerven. Pfugers Arch.9, 174–197 (1874).Google Scholar
  7. [7]
    J. N. Langley,On axon reflexes in the preganglionic fibres of the sympathetic system. J. Physiol. (Lond)25, 364–398 (1900).Google Scholar
  8. [8]
    W. M. Bayliss,On the origin from the spinal cord of the vasodilator fibres of the hind limb, and on the nature of these fibres. J. Physiol. (Lond)36, 173–209 (1901).Google Scholar
  9. [9]
    O. Celander and B. Folkow,The nature and distribution of afferent fibres provided with the axon reflex arrangement. Acta Physiol. Scand.29, 359–370 (1953).PubMedGoogle Scholar
  10. [10]
    J. Van-Hees and J. M. Gybels,Pain related to single afferent C fibres from human skin. Brain Res.48, 397–400 (1972).PubMedGoogle Scholar
  11. [11]
    H. E. Torebjork and R. G. Hallin,Identification of afferent C units in intact human skin. Brain Res.67, 387–403, (1974).PubMedGoogle Scholar
  12. [12]
    P. Kenins,Identification of the unmyelinated sensory nerves which evoke plasma extravasation in response to antidromic stimulation. Neurosci Lett.25, 137–141 (1981).PubMedGoogle Scholar
  13. [13]
    T. Hokfelt, J. O. Kellerth, G. Nillson and B. Pernow,Experimental immunohistochemical studies on the localization and distribution of substance P in cat primary sensory neurones. Brain Res.100, 235–252 (1975).PubMedGoogle Scholar
  14. [14]
    E. Brodin, B. Gazelius, J. M. Lundberg, and L. Olgart,Substance P in trigeminal nerve endings: occurrence and release. Acta Physiol. Scand.111, 501–503 (1983).Google Scholar
  15. [15]
    D. M. White and R. P. Helm,Release of substance P from peripheral nerve terminals following electrical stimulation of the sciatic nerve. Brain Res.336, 27–31 (1985).PubMedGoogle Scholar
  16. [16]
    P. Keen, A. J. Harmar, F. Spears and E. Winter,Biosynthesis, axonal transport and turnover of neuronal substance P. InSubstance P in the nervous system. Ciba Foundation Symposium. (Eds. R. Porter and M. O'Connor pp. 145–164. London, Pitman 1982.Google Scholar
  17. [17]
    H. Nawa, T. Hirose, H. Takashima, S. Inayama and S. Nakanishi,Nucleotide sequences of cloned CDNA's for two types of bovine brain substance P preursor. Nature306, 32–36 (1983).PubMedGoogle Scholar
  18. [18]
    H. Nawa, H. Kotani and S. Nakanishi,Tissue generation of two preprotachykinin mRNAs from one gene by alternative RNA spacing. Nature312, 729–734 (1984).PubMedGoogle Scholar
  19. [19]
    J. Fisher, W. G. Forssman, T. Hokfelt, J. M. Lundberg, M. Rienecke, F. A. Tschopp and Z. Wiesenfeld Hakin,Immunoreactive calcitonin gene-related peptide and substance P: coexistence in sensory neurones and behavioural interaction after intrathecal administration in the rat. J. Physiol. (Lond)362 329P (1983).Google Scholar
  20. [20]
    O. Hagermark, T. Hokfelt and B. Pernow,Flare and itch induced by substance P in human skin. J. Invest. Dermatol.71, 233–235 (1978).PubMedGoogle Scholar
  21. [21]
    P. Anand, S. R. Bloom and G. P. McGregor,Topical capsaicin pretreatment inhibits axon reflex vasodilation caused by somatostatin and vasoactive polypeptide in human skin, Br. J. Pharmacol.78, 665–669 (1983).PubMedGoogle Scholar
  22. [22]
    J. C. Foreman, C. C. Jordan, P. Oehme and H. Renner,Structure-activity relationships for some substance P-related peptides that cause wheal and flare rections in human skin. J. Physiol. (Lond)335, 449–465 (1983).Google Scholar
  23. [23]
    J. C. Foreman and W. Piotrowski,Some effects of substance P antagonists on mast cells. InTachykinin Antagonists. (Eds. R. Hakanson and F. Sundler) pp. 405–412, Amsterdam, Elsevier 1985.Google Scholar
  24. [24]
    S. D. Brain, J. R. Tippins, H. R. Morris, I. MacIntyre and T. J. Williams,Potent vasodilator activity of calcitonin generelated peptide in human skin. J. Invest. Dermatol.87, 533–536 (1986).PubMedGoogle Scholar
  25. [25]
    E. Theriault, M. Otsuka and T. JesselCapsaicin-evoked release of substance P from primary sensory neurones. Brain Res.170, 209–213 (1979).PubMedGoogle Scholar
  26. [26]
    I. Toth-Kasa, G., Jancso, F., Obal, S. Husz and N. Simon,Involvement of sensory nerve endings in the cold and heat urticaria. J. Invest. Dermatol.80, 34–36 (1983).PubMedGoogle Scholar
  27. [27]
    A. Saria and J. M. Lundberg,Capsaicin pretreatment inhibits heat-induced oedema in rat skin. Naunyn Schmiedeberg's Arch. Pharmacol.323, 341–342 (1983).Google Scholar
  28. [28]
    A. R. Johnson and E. G. Erdos,Release of histamine from mast cells by vasoactive peptides. Proc. Soc. Exp. Biol. Med.142, 1252–1256 (1973).PubMedGoogle Scholar
  29. [29]
    J. C. Foreman, C. C. Jordan and W. Pietrowski,Interaction of neurotensin with the substance P receptor mediating histamine release from rat mast cells and the flare in human skin. Br. J. Pharmacol.77, 531–539 (1982).PubMedGoogle Scholar
  30. [30]
    A. P. Kaplan, L. Gray, R. E. Shaff, Z. Horakova and M. A. Beaven,In vivo studies of mediator release in cold urticaria and cholinergic urticaria. J. Allergy Clin. Immunol.55, 394–402 (1975).PubMedGoogle Scholar
  31. [31]
    D. J. Heavey, A. Kobza-Black, S. E. Barrow, C. G. Chappell, M. W. Greaves and C. T. Dollery,Prostaglandin D2 and histamine release in cold urticaria. J. Allergy Clin. Immunol.78, 458–461 (1986).PubMedGoogle Scholar
  32. [32]
    O. Koro, J. S. Dover, D. M. Francis, A. Kobza-Black, R. W. Kelly, R. M. Barr and M. W. Greaves,Release of prostaglandin D2 and histamine in a case of localized heat urticaria and effects of treatments. Br. J. Dermatol.115, 721–728 (1986).PubMedGoogle Scholar
  33. [33]
    M. D. Tharp, R. T., Suvunrungsi and T. J. Sullivan,IgEmediated release of histamine from human cutaneous mast cells. J. Immunol.130, 1896–1901 (1983).PubMedGoogle Scholar
  34. [34]
    R. C. Benyon, M. A. Lowman and M. K. Church,Human skin mast cells: their dispersion, purification and secretory characterization. J. Immunol.138, 861–867 (1987).PubMedGoogle Scholar
  35. [35]
    I. Kimura, Y. Moritani and Y. Tanizaki,Basophils in bronchial asthma with reference to reagin-type allergy. Clin. Allergy3, 195–202 (1973).PubMedGoogle Scholar
  36. [36]
    M. K. Church, G. J.-K. Pao and S. T. Holgate,Characterization of histamine secretion from dispersed human lung mast cells: effects of anti-IgE, calcium ionophore A23187, compound 48/80 and basic polypeptides. J. Immunol.129, 2116–2121 (1982).PubMedGoogle Scholar
  37. [37]
    M. A. Lowman, P. H. Rees, R. C. Benyon and M. K. Church,Human mast cell heterogeneity: Histamine release from mast cells dispersed from skin, lung, adenoids, tonsils and intestinal mucosa in response to IgE-dependent and non-immunological stimuli. J. Allergy Clin. Immunol.81, 590–597 (1988).PubMedGoogle Scholar
  38. [38]
    P. H. Rees, K. Hillier and M. K. Church,The secretory characteristics of mast cells isolated from human intestinal mucosa and muscle. Immunology65, 437–442 (1988).PubMedGoogle Scholar
  39. [39]
    M. A. Lowman, R. C. Benyon and M. K. Church,Characterization of neuropeptide-induced histamine release from human dispersed skin mast cells. Br. J. Pharmacol.95, 121–130 (1988).PubMedGoogle Scholar
  40. [40]
    F. Shanahan, J. A. Denburg, J. Fox, J. Bienenstock and D. Befus,Mast cell heterogeneity: effects of neuroenteric peptides on histamine release. J. Immunol.135, 1331–1337 (1985).PubMedGoogle Scholar
  41. [41]
    F. A. Horner and R. K. Winkelman,Histamine release produced in human skin by compound 48/80. Ann. Allergy26, 107–116 (1968).PubMedGoogle Scholar
  42. [42]
    T. B. Casale, S. Bowman and M. Kaliner,Induction of human cutaneous mast cell degranulation by opiates and endogenous opioid peptides: evidence for opiate and nonopiate receptor participation. J. Allergy Clin. Immunol.73, 775–781 (1984).PubMedGoogle Scholar
  43. [43]
    T. D. G. Lee, M. Swieter, J. Bienenstock and A. D. Befus,Heterogeneity in mast cell populations. Clin. Immunol. Rev.4, 143–199 (1985).PubMedGoogle Scholar
  44. [44]
    C. M. Fewtrell, J. C. Foreman, C. C. Jordan, P. Oehme, H. Renner and J. M. Stewart,The effects of substance P on histamine and 5-hydroxytryptamine release in the rat. J. Physiol. (Lond)330, 393–411 (1982).Google Scholar
  45. [45]
    H. Repke, W. Piotrowski, M. Bienert and J. C. Foreman,Histamine release induced by Arg-Pro-Lys-Pro(CH 2)11 CH 3 from rat peritoneal mast cells. J. Pharmacol. Exp. Ther.243, 317–321 (1987).PubMedGoogle Scholar
  46. [46]
    W. Piotrowski, M. A. B. Devoy, C. C. Jordan and J. C. Foreman,The substance P receptor on rat mast cells and in human skin. Agents and Actions14, 420–423 (1984).PubMedGoogle Scholar
  47. [47]
    R. C. Benyon, C. Robinson, S. T. Holgate and M. K. Church,Prostaglandin D2 release from human skin mast cells in response to ionophore A23187. Br. J. Pharmacol.92, 635–638 (1987).PubMedGoogle Scholar
  48. [48]
    C. Robinson, R. C. Benyon, S. T. Holgate and M. K. Church,The IgE- and calcium-dependent release of eicosanoids and histamine from human cutaneous mast cells. (submitted).Google Scholar
  49. [49]
    R. C. Benyon, C. Robinson and M. K. Church,Differential release of histamine and eicosanoids from human skin mast cells by IgE-dependent and non-immunological stimuli. (submitted).Google Scholar
  50. [50]
    E. J. Goetzl, M. J. Phillips and W. M. Gold,Stimulus specificity of the generation of leukotrienes by dog mastocytoma cells. J. Exp. Med.158, 731–737 (1983).PubMedGoogle Scholar
  51. [51]
    S. R. Findlay, L. M. Lichtenstein and J. A. Grant,Generation of slow reacting substance from human leukocytes. II. Comparison of stimulation by antigens, calcium ionophore and C5 peptide. J. Immunol.124, 238–242 (1980).PubMedGoogle Scholar
  52. [52]
    Y. Kitamura, T. Nakano, Y. Kanakura and H. Matsuda,Factors influencing mast cell differention. InProceedings of the XII. International Congress of Allergy and Clinical Immunology. (Ed. C. E. Reed) J. Allergy. Clin. Immunol. pp. 154–158, St. Louis 1986.Google Scholar
  53. [53]
    E. E. E. Jarrett and H. R. P. Miller,Production and activities of IgE in helminth infection. Prog. Allergy31, 178–233 (1982).PubMedGoogle Scholar
  54. [54]
    J. N. Ihle, J. Keller, S. Oroszlan, L. E. Henderson, T. D. Copeland, F. Fitch, M. B. Prytsowsky, E. Goldwasser, J. W. Schrader, E. Palaszynski, M. Dy and B. Lebel,Biological properties of homogenous interleukin 3: Demonstration of WEHI-3 growth factor activity, mast cell growth factor activity, P-cell stimulating factor activity, colony-stimulating activity and histamine producing cell stimulating factor activity. J. Immunol.131, 282–287 (1983).PubMedGoogle Scholar
  55. [55]
    K. Hirai, A. L. De Weck and B. M. Stadler,Characterization of a human basophil-like cell promoting activity. J. Immunol.140, 221–227 (1988).PubMedGoogle Scholar
  56. [56]
    L. Wiesner-Menzel, B. Schulz, F. Vakilzadeh and B. M. Czarnetzki,Electron microscopical evidence for a direct contact between nerve fibres and mast cells. Acta Derm. Venereol. (Stockh.)61, 465–469 (1981).Google Scholar
  57. [57]
    J. C. Foreman and W. Piotrowski,Peptides and histamine release. J. Allergy Clin. Immunol.74, 127–131 (1984).PubMedGoogle Scholar
  58. [58]
    L. Enerbäck,Mast cell heterogeneity: The evolution of the concept of a specific mucosal mast cell. InMast cell differentiation and heterogeneity. (Eds. A. D. Befus, J. Bienenstock, J. A. Denburg) pp. 1–26, New York, Raven Press 1986.Google Scholar
  59. [59]
    R. G. Woodbury and H. R. P. Miller,Quantitative analysis of mucosal mast cell protease in the intestine of Nippostrongylus-infected rats. Immunology46, 487–495 (1982).PubMedGoogle Scholar
  60. [60]
    L. B. Schwartz,Monoclonal antibodies against human mast cell tryptase demonstrate shared antigenic sites on subunits of tryptase and selective localization of the enzyme to mast cells. J. Immunol.134, 526–531 (1985).PubMedGoogle Scholar
  61. [61]
    N. M. Schechter, J. K. Choi, D. A. Slavin, D. T. Deresienski, S. Sayama, G. Dong, R. M. Lavaker, D. Proud and G. S. Lazarus,Identifikation of a chymotrypsin-like proteinase from human mast cells. J. Immunol.137, 962–970 (1986).PubMedGoogle Scholar
  62. [62]
    A. A. Irani, N. M. Schechter, S. Craig, G. DeBlois and L. B. Schwartz,Two types of human mast cells that have distinct neutral protease compositions. Proc. Natl. Acad. Sci USA83, 4464–4468 (1986).PubMedGoogle Scholar
  63. [63]
    L. B. Schwartz, A. M. Irani, K. Roller, M. Castells and N. M. Schechter,Quantitation of histamine, tryptase, and chymase in dispersed human T and CT mast cells. J. Immunol.138, 2611–2615 (1987).PubMedGoogle Scholar
  64. [64]
    A. A. Irani, R. Buckley, B. Haynes, N. M. Schechter and L. B. Schwartz,Selective depletion of T mast cells in intestinal mucosa of patients with defective lymphocyte function (Abstract). J. Allergy Clin. Immunol.79, 178 (1987).Google Scholar
  65. [65]
    S. Strobel, H. R. P. Miller and A. Ferguson,Human intestinal mucosal mast cells: evaluation of fixation and staining techniques. J. Clin. Pathol.34, 851–858 (1981).PubMedGoogle Scholar
  66. [66]
    A. D. Befus, R. Goodacre, N. Dyck and J. Bienenstock,Mast cell heterogeneity in man. I. Histologic studies of the intestine. Int. Arch. Allergy Appl. Immunol.76, 232–236 (1985).PubMedGoogle Scholar
  67. [67]
    K. C. Flint, K. B. P. Leung, F. L. Pearce, B. N. Hudspith, J. Brostoff and N. McI. Johnson,Human mast cells recovered from bronchoalveolar lavage: their morphology, histamine release and effects of sodium cromoglycate. Clin. Sci.68, 427–432 (1985).PubMedGoogle Scholar
  68. [68]
    S. T. Holgate, P. Rafferty, R. Beasley, C. Robinson, C. J. Hovell, N. P. Curzen and M. K. Church,In vitro and in vivo studies on mast cells of human skin and airways. InAllergy and inflammation. (Ed. A. B. Kay) pp. 29–52, London, Academic Press 1987.Google Scholar
  69. [69]
    C. C. Fox, A. M. Dvorak, S. P. Peters, A. Kagey-Sobotka and L. M. Lichtenstein,Isolation and characterization of human intestinal mucosal mast cells. J. Immunol.135, 483–491 (1985).PubMedGoogle Scholar
  70. [70]
    R. M. Marks, W. R. Roche, M. Czerniecki, R. Penny and D. S. Nelson,Mast cell granules cause proliferation of human microvascular endothelial cells. Lab. Invest.55, 289–294 (1986).PubMedGoogle Scholar
  71. [71]
    R. W. Schayer,Evidence that induced histamine is an intrinsic regulator of the microcirculatory system. Am. J. Physiol.202, 66–72 (1962).PubMedGoogle Scholar
  72. [72]
    H. Zachariae,Histamine in human skin. Arch. Dermatol. Venereol.44, 219–222 (1964).Google Scholar
  73. [73]
    P. M. Bedard, C. Brunet, G. Pelletier and J. Hebert,Increased compound 48/80 induced local histamine release from non-lesional skin from patients with chronic urticaria. J. Allergy Clin. Immunol.78, 1121–1125 (1986).PubMedGoogle Scholar
  74. [74]
    R. W. Cohen und D. L. Rosenstreich,Discrimination between urticaria-prone and other allergic patients by intradermal skin testing with codeine. J. Allergy Clin. Immunol.77, 802–807 (1986).PubMedGoogle Scholar
  75. [75]
    J. C. Foreman,Neuropeptides and the pathogenesis of allergy. Allergy42, 1–11 (1987).PubMedGoogle Scholar
  76. [76]
    M. K. Church, M. A. Lowman, C. Robinson, S. T. Holgate and R. C. Benyon,Interaction of neuropeptides with human mast cells. Int. Arch. Allergy Appl. Immunol. (in press).Google Scholar

Copyright information

© Birkhäuser Verlag 1989

Authors and Affiliations

  • M. K. Church
    • 1
  • M. A. Lowman
    • 1
  • P. H. Rees
    • 1
  • R. C. Benyon
    • 1
  1. 1.Immunopharmacology Group, Clinical Pharmacology, Centre BlockSouthampton General HospitalSouthamptonUK

Personalised recommendations